We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells.
- Authors
Aasebø, Elise; Brenner, Annette K.; Hernandez-Valladares, Maria; Birkeland, Even; Berven, Frode S.; Selheim, Frode; Bruserud, Øystein
- Abstract
Mesenchymal stem cells (MSCs) can differentiate into osteoblasts, and therapeutic targeting of these cells is considered both for malignant and non-malignant diseases. We analyzed global proteomic profiles for osteoblasts derived from ten and MSCs from six healthy individuals, and we quantified 5465 proteins for the osteoblasts and 5420 proteins for the MSCs. There was a large overlap in the profiles for the two cell types; 156 proteins were quantified only in osteoblasts and 111 proteins only for the MSCs. The osteoblast-specific proteins included several extracellular matrix proteins and a network including 27 proteins that influence intracellular signaling (Wnt/Notch/Bone morphogenic protein pathways) and bone mineralization. The osteoblasts and MSCs showed only minor age- and sex-dependent proteomic differences. Finally, the osteoblast and MSC proteomic profiles were altered by ex vivo culture in serum-free media. We conclude that although the proteomic profiles of osteoblasts and MSCs show many similarities, we identified several osteoblast-specific extracellular matrix proteins and an osteoblast-specific intracellular signaling network. Therapeutic targeting of these proteins will possibly have minor effects on MSCs. Furthermore, the use of ex vivo cultured osteoblasts/MSCs in clinical medicine will require careful standardization of the ex vivo handling of the cells.
- Subjects
MESENCHYMAL stem cells; INTERLEUKIN-27; EXTRACELLULAR matrix proteins; BONE marrow; PROTEOMICS; SERUM-free culture media
- Publication
International Journal of Molecular Sciences, 2021, Vol 22, Issue 11, p5665
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms22115665